Cite

HARVARD Citation

    Hamid, O. et al. (2018). Antitumour activity of pembrolizumab in advanced mucosal melanoma: a post-hoc analysis of KEYNOTE-001, 002, 006. British journal of cancer. 119 (6), pp. 670-674. [Online]. 
  
Back to record